Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 2/2021

Ausgabe 2/2021

Inhaltsverzeichnis ( 14 Artikel )

09.01.2021 | Review Article | Ausgabe 2/2021

Tumor microenvironment promotes breast cancer chemoresistance

Umar Mehraj, Abid Hamid Dar, Nissar A. Wani, Manzoor A. Mir

10.01.2021 | Review Article | Ausgabe 2/2021

Disulfiram: a novel repurposed drug for cancer therapy

Chen Lu, Xinyan Li, Yongya Ren, Xiao Zhang

11.10.2020 | Original Article | Ausgabe 2/2021 Open Access

Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid

Milene Volpato, Nicola Ingram, Sarah L Perry, Jade Spencer, Amanda D Race, Catriona Marshall, John M Hutchinson, Anna Nicolaou, Paul M Loadman, P Louise Coletta, Mark A Hull

04.11.2020 | Original Article | Ausgabe 2/2021 Open Access

Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types

Nadia Terranova, Mendel Jansen, Martin Falk, Bart S. Hendriks

10.11.2020 | Original Article | Ausgabe 2/2021 Open Access

Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors

Timothy Crook, Andrew Gaya, Raymond Page, Sewanti Limaye, Anantbhushan Ranade, Amit Bhatt, Sanket Patil, Prashant Kumar, Darshana Patil, Dadasaheb Akolkar

21.11.2020 | Original Article | Ausgabe 2/2021

PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1

Shuo Yu, Yang Li, Hui Ren, Hong Zhou, Qian Ning, Xue Chen, Tinghua Hu, Lan Yang

23.11.2020 | Original Article | Ausgabe 2/2021

Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma

Haofeng Lu, Lin Zhou, Hongping Zuo, Wenjin Le, Jianfei Hu, Tiequan Zhang, Mi Li, Yufeng Yuan

02.01.2021 | Original Article | Ausgabe 2/2021

Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients

Nastja Lunar, Marie-Christine Etienne-Grimaldi, Pauline Macaire, Fabienne Thomas, Florence Dalenc, Jean-Marc Ferrero, Xavier Pivot, Gérard Milano, Bernard Royer, Antonin Schmitt

03.01.2021 | Original Article | Ausgabe 2/2021 Open Access

Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers

Naveed Shaik, Robert R. LaBadie, Brian Hee, Geoffrey Chan

04.01.2021 | Original Article | Ausgabe 2/2021

Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer

Akira Yamagata, Toshihide Yokoyama, Yasushi Fukuda, Tadashi Ishida

05.01.2021 | Original Article | Ausgabe 2/2021

Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair

Gloria Ciniero, Ahmed H. Elmenoufy, Francesco Gentile, Michael Weinfeld, Marco A. Deriu, Frederick G. West, Jack A. Tuszynski, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim

23.01.2021 | Original Article | Ausgabe 2/2021

Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors

R. B. Verheijen, T. T. van Duijl, M. M. van den Heuvel, D. Vessies, M. Muller, J. H. Beijnen, J. M. Janssen, J. H. M. Schellens, N. Steeghs, D. van den Broek, A. D. R. Huitema

29.01.2021 | Original Article | Ausgabe 2/2021

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane

Maria Spiliotaki, Galatea Kallergi, Christos Nikolaou, Nikolaos Xenidis, Eleni Politaki, Stella Apostolaki, Nefeli Georgoulia, Filippos Koinis, Nikolaos Tsoukalas, Dora Hatzidaki, Athanasios Kotsakis, Vassilis Georgoulias

03.01.2021 | Short Communication | Ausgabe 2/2021

Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review

Malvi Savani, Katti Woerner, Lihong Bu, Mark Birkenbach, Keith M. Skubitz

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise